A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice

Genes Chromosomes and Cancer

Volumn 25, Issue 3, 1999, Pages 251-260

  Weaver, Zoë A ^a,c   McCormack, Stephen J ^b,d   Liyanage, Marek ^a,e   Du Manoir, Stan ^a,f   Coleman, Allen ^c   Schröck, Evelin ^a   Dickson, Robert B ^b   Ried, Thomas ^a,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d GEORGE MASON UNIVERSITY   (United States)

^e Aurora Biosciences Corporation   (United States)

^f INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BREAST TUMOR; CELL LINE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE MUTATION; KARYOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 8; DISEASE MODELS, ANIMAL; GENE AMPLIFICATION; GENES, MYC; HUMANS; KARYOTYPING; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; NUCLEIC ACID HYBRIDIZATION; PLOIDIES; RETROVIRIDAE INFECTIONS; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; RODENTIA;

EID: 0033040912     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199907)25:3<251::AID-GCC7>3.0.CO;2-3     Document Type: Article

References (28)

1. Amundadottir LT, Johnson MD, Merlino G, Smith G, Dickson RB. 1995. Synergistic interaction of transforming growth factor α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Diff 6:737-748.
2. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. 1996. Atm deficient mice: a paradigm of ataxia-telangectasia. Cell 86:159-171.
3. Bärlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A. 1997. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer 20:372-376.
4. Bièche I. Champème M-H, Lidereau R. 1994. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res 54:4274-4276.
5. Bièche I, Tomasetto C, Regnier CH, Moog-Lutz C, Rio MC, Lidereau R. 1996. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. Cancer Res 56:3886-3890.
6. Coleman AE, Schröck E, Weaver Z, du Manoir S, Yang F, Ferguson-Smith MA, Ried T, Janz S. 1997. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping. Cancer Res 57:4585-4592.
7. Davisson MT. 1996. Rules for nomenclature of chromosome anamolies. In Lyon MF, Rastan S, Brown SDM, editors. Genetic variants and strains of the laboratory mouse, 3rd ed. New York: Oxford University Press, p 1443-1445.
8. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D, Varmus HE. 1995. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9:882-895.
9. du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T. 1995. Quantitative analysis of comparative genomic hybridization. Cytometry 19:24-41.
10. Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11:181-190.
11. Ghadimi BM, Schröck E, Walker RL, Wangsa D, Jauho A, Meltzer PS, Ried T. 1999. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 154:525-536.
12. Heim S, Mitelman F. 1995. Cancer Cytogenetics, 2nd ed. New York: Wiley-Liss.
13. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
14. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM. 1994. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
15. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P. 1986. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45:485-495.
16. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
17. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow D, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schröck E, Ried T. 1996. Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 14:312-315.
18. Macville M, Schröck E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, Ried T. 1999. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59:141-150.
19. McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB. 1998. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene 16:2755-2766.
20. Nass SJ, Dickson RB. 1997. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res Treat 44:1-22.
21. Nishizaki T, DeVries S, Chew K, Goodson WH III, Ljung BM, Thor A, Waldman FM. 1997. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19:267-272.
22. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schröck E, Latham C, Blegen H, Zetterberg A, Cremer T, Auer G. 1995. Comparative genomic hybridization of formalin fixed, paraffin embedded breast carcinomas reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55:5415-5423.
23. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human chromosomes. Science 273:494-497.
24. Shi YP, Naik P, Dietrich WF, Gray JW, Hanahan D, Pinkel D. 1997. DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice. Genes Chromosomes Cancer 19:104-111.
25. Stewart TA, Pattengale PK, Leder P. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627-637.
26. Taylor C, Jalava A, Mai S. 1997. C-Myc dependent initiation of genomic instability during neoplastic transformation. Curr Topics Microbiol Immunol 224:201-207.
27. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi O. 1998. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21:177-184.
28. Tsukamoto K, Ito N, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G. Nakamura Y, Emi M. 1998. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer 82:317-322.